Evidence-Based Review on Symptomatic Management of Huntington's Disease

Jung Hwan Shin1, Hui-Jun Yang2, Jong Hyun Ahn3

  • 1Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

PubMed

Insights

This review systematically examines interventions for Huntington

Area of Science:

  • Neuroscience and Neurology
  • Clinical Medicine

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder impacting motor, cognitive, and behavioral functions.
  • HD significantly diminishes patient quality of life, necessitating effective symptomatic management strategies.

Purpose of the Study:

  • To systematically review current pharmacological and nonpharmacological interventions for managing 23 symptoms of Huntington's disease.
  • To provide an evidence-based summary for the symptomatic treatment of HD.

Main Methods:

  • Systematic literature search adhering to PRISMA guidelines, covering studies up to August 2022.
  • Analysis focused on interventions targeting motor, neuropsychological, cognitive, and other symptom domains of HD.

Main Results:

  • Identified and reviewed existing interventions for a wide spectrum of Huntington's disease symptoms.
  • Highlighted the current state of evidence for various management approaches.

Conclusions:

  • A comprehensive overview of symptomatic management for Huntington's disease is presented.
  • Emphasizes the critical need for more high-quality clinical trials to establish robust, evidence-based guidelines for HD care.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
155
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K